Company
Althea Group Holdings Limited
Headquarters: Melbourne, VIC, Australia
CEO: Mr. Joshua Fegan
Market Cap
A$14.7 Million
AUD as of Jan. 1, 2024
US$10.0 Million
Althea Group Holdings Limited Categories
Australia Healthcare Drug Manufacturers—Specialty & GenericAustralia Healthcare Australia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Althea Group Holdings Limited manufactures, sells, and distributes pharmaceutical grade medicinal cannabis in Australia, the United Kingdom, Africa, and Canada. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways through Concierge, an online service, as well as Medic, an online education. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, and topicals. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Althea Group Holdings Limited has the following listings and related stock indices.
Stock: ASX: AGH wb_incandescent